SCHEMBL9657865

SCHEMBL9657865

CCOc1c(OCC)c(O)c2cc(OC)ccc2c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ TSHR P16473 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ NQO1 P15559 3/20 0.40
▸ TUBB4A P04350 1/20 0.40
▸ TUBB P07437 1/20 0.40
▸ TUBA3C P0DPH7 1/20 0.40
▸ TUBA1B P68363 1/20 0.40
▸ TUBA4A P68366 1/20 0.40
▸ TUBB4B P68371 1/20 0.40
▸ TUBB3 Q13509 1/20 0.40
▸ TUBB2A Q13885 1/20 0.40
▸ TUBB8 Q3ZCM7 1/20 0.40
▸ TUBA3E Q6PEY2 1/20 0.40
▸ TUBA1A Q71U36 1/20 0.40
▸ TUBA1C Q9BQE3 1/20 0.40
▸ TUBB6 Q9BUF5 1/20 0.40
▸ TUBB2B Q9BVA1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9654941 0.86 MAPT (0.47) MAPTALDH1A1HSD17B10TSHRMAPK1
SCHEMBL9449015 0.83 MAPT (0.45) MAPTALDH1A1HSD17B10TSHRNQO1
SCHEMBL6273226 0.81 ALDH1A1 (0.50) MAPTALDH1A1HSD17B10TSHRMAPK1
SCHEMBL9657047 0.81 ALDH1A1 (0.47) MAPTALDH1A1HSD17B10TSHRMAPK1
SCHEMBL9657675 0.80 NQO1 (0.44) MAPTALDH1A1HSD17B10TSHRNQO1
SCHEMBL9657735 0.77 TSHR (0.43) MAPTALDH1A1HSD17B10TSHRMAPK1
SCHEMBL8489307 0.76 NQO1 (0.65) MAPTALDH1A1HSD17B10NQO1MEN1
SCHEMBL8838773 0.76 MAPT (0.52) MAPTALDH1A1HSD17B10TSHRMEN1
SCHEMBL9448851 0.75 GAA (0.41) MAPTALDH1A1TSHRNQO1MEN1
SCHEMBL11064590 0.75 MAPT (0.50) MAPTALDH1A1HSD17B10MAPK1NQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 — — US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 — — US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 — — EP disclosed
Send feedback